CClinicalTrials.gg
CompletedNCT04208815Updated Jan 13, 2022

Evaluation of Dietary Milk Polar Lipids on Serum Cholesterol and Gut Microbiota in Healthy Adults

An interventional study of Milk Polar Lipids and Milk Fat in Serum Cholesterol and Gut Microbiome, sponsored by University of Connecticut. Completed at 1 site in United States. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-01-13.

Sponsored by University of Connecticut · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Study summary

The purpose of this study is to examine whether the daily consumption of 5 g of milk polar lipids influences serum lipids and gut microbiota composition in healthy adults.

Read the detailed description

Healthy adults will be recruited to participate in a randomized, single-blind, controlled, 13-week crossover trial. Participants will follow a 2-week run-in control period consuming their habitual diets. Participants will then be randomized to consume 20 g of milk fat daily in the form of either a reconstituted milk polar lipid (MPL)-rich dairy beverage (MPL; providing 5.3 g MPL daily) or a control dairy beverage (CTL; providing 0.3 g MPL daily), each for 4- weeks, separated by a 3-week washout period. Participants will be instructed to consume intervention treatment/control beverages at breakfast (50 g) and dinner (50 g) and reconstitute the powders in water immediately prior to consumption. With the exception of the intervention beverages, participants will be asked to maintain their normal diet and exercise habits throughout the study. Venous blood will be collected after a 12-hour overnight fast into EDTA-coated (glucose analysis) and serum (lipid analyses) collection tubes. Passive drool and stool samples will be collected at the end of the run-in period (baseline) and intervention periods (treatment and control). Participants will be asked to complete a 5-day dietary record, food preference/liking/sedentary behavior surveys, and 7-day physical activity diary at the beginning and end of intervention periods.

02

Conditions studied

  • Serum Cholesterol
  • Gut Microbiome

Keywords

  • Milk
  • Polar Lipids
  • Phospholipids
  • Cholesterol
  • Microbiota
  • Microbiome
03

In context

Lead sponsor

University of Connecticut is the lead sponsor of 133 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Aged 18 to 50 years
  • Body Mass Index \< 30 kg/m\^2
  • Willing to consume experimental intervention products on a daily basis

Exclusion criteria

Exclusion Criteria:

  • Outside of age range (\<18 or >50 years old)
  • Body Mass Index > 30 kg/m\^2
  • Triglycerides are higher than 500 mg/dL, glucose levels higher than 126 mg/dL, or total cholesterol higher than 240 mg/dL
  • Self-reported history of renal or liver disease, diabetes, thyroid disease, gallbladder disease, eating disorders, heart disease, stroke, cancer and gut-associated pathologies
  • Weight loss greater than 10% of body weight over preceding 4 weeks
  • Taking probiotic supplements or oral antibiotics up to 1 month prior to the study and during the study
  • Allergy to dairy or lactose intolerance
  • Taking lipid-lowering medications
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
35 participants (actual)

Study arms

  • Experimental
    MPL-rich dairy beverage

    Daily consumption of 100 g of dairy powder containing 5.3 g MPL for 4 weeks

    Other: Milk Polar Lipids · Other: Milk Fat

  • Placebo comparator
    Control dairy beverage

    Daily consumption of 100 g of dairy powder containing 0.3 g MPL for 4 weeks

    Other: Milk Fat

Interventions

  • OtherMilk Polar Lipids

    Effects of the addition of 5 g of milk polar lipids to 20 g milk fat.

  • OtherMilk Fat

    Effects of the addition of 20 g milk fat.

06

What researchers measure

Primary outcomes

  1. Change from Baseline Serum Total Cholesterol at 4 weeks

    Measurement of serum cholesterol (mg/dL) at the beginning and end of each 4-week intervention arms.

    Time frame: 4 weeks

Secondary outcomes

  1. Change in Fecal Microbiota Shannon Index at 4 weeks

    Measurement of fecal microbiota Shannon Index at the end of each 4-week intervention arms.

    Time frame: 4 weeks

07

Study locations

1 site
  • University of Connecticut
    Storrs, Connecticut 06269, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 13, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04208815
Lead sponsor
University of Connecticut
Responsible party
Christopher Blesso (Associate Professor, University of Connecticut) — Principal investigator
First posted
Dec 23, 2019
Start date
Mar 1, 2020
Primary completion
Oct 31, 2021
Completion
Oct 31, 2021
Last update
Jan 13, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion